Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000005

CEO and CFO bought 3,200 shares at $11.12 ($35,584)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2024-12-30 Purchase +3,200 $11.12 $35,584 5,539,302 D
Open-market purchases · 3,200 sh · avg $11.12 · $35,584
Loading xslF345X05/ownership.xml…